The WHO pointers stipulate that manufacturers have to build and adhere to in depth routine maintenance schedules based upon products requirements and usage designs. Manufacturers wanting to apply these strategies should offer robust validation information to demonstrate their equivalence to pharmacopoeial techniques. As these new systems